novelstem_logo.jpg
NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing for Approval of its Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; NovelStem Initiates Process to Become Publicly-Reporting with S.E.C. and to Up-List its Shares
01 déc. 2020 08h33 HE | NovelStem International Corp.
BOCA RATON, Fla. and JERUSALEM, Dec. 01, 2020 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on its stem cell-based technology platform,...
novelstem_logo.jpg
NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and COVID-19 Resistance; Reports Progress Identifying Genetic Resistance to Additional Anti-Cancer Treatments
21 avr. 2020 08h30 HE | NovelStem International Corp.
Screening of resistance diagnostics completed for twelve standard-of-care cancer treatments representing a significant portion of cancer treatment protocols. COVID-19 research collaboration initiated...
novelstem_logo.jpg
NovelStem Increases NewStem Ownership to 27.3% Following Achievement of Development Milestones for Stem-Cell-Based Cancer Treatments Resistance Diagnostic
16 déc. 2019 08h07 HE | NovelStem International Corp.
BOCA RATON, Fla. and JERUSALEM, Israel, Dec. 16, 2019 (GLOBE NEWSWIRE) -- NovelStem International Corp. (OTC Pink: NSTM), a biotechnology company focused on stem-cell-based diagnostic technology to...
novelstem_logo.jpg
Hollywood Media Changes Name and Stock Symbol to NovelStem International Corp. and “NSTM” to Reflect Focus on Stem Cell-Based Diagnostics to Better Select Cancer Chemotherapies
25 sept. 2018 16h02 HE | NovelStem International Corp.
BOCA RATON, Fla. and JERUSALEM, Israel, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Hollywood Media Corp. (OTC Pink: HOLL) announced today it has changed its corporate name to NovelStem International Corp....
Hollywood Media Comp
Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer of Haploid Stem Cell-Based Diagnostics to Predict Chemotherapy Resistance
16 juil. 2018 01h00 HE | Hollywood Media Corp.
Raises $1.925 Million to Support a $2 Million Initial Investment in NewStem Ltd.Appoints New Board of Directors Led by Jan Loeb as ChairmanForms New Leadership Team with Deep Healthcare ExpertisePlans...